Log in to save to my catalogue

Predicting the efficacy of bevacizumab on peritumoral edema based on imaging features and machine le...

Predicting the efficacy of bevacizumab on peritumoral edema based on imaging features and machine le...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e62fc44de1e44d1db8f2cf0461b478ff

Predicting the efficacy of bevacizumab on peritumoral edema based on imaging features and machine learning

About this item

Full title

Predicting the efficacy of bevacizumab on peritumoral edema based on imaging features and machine learning

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2025-05, Vol.15 (1), p.15990-12, Article 15990

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

This study proposes a novel approach to predict the efficacy of bevacizumab (BEV) in treating peritumoral edema in metastatic brain tumor patients by integrating advanced machine learning (ML) techniques with comprehensive imaging and clinical data. A retrospective analysis was performed on 300 patients who received BEV treatment from September 201...

Alternative Titles

Full title

Predicting the efficacy of bevacizumab on peritumoral edema based on imaging features and machine learning

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e62fc44de1e44d1db8f2cf0461b478ff

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e62fc44de1e44d1db8f2cf0461b478ff

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-025-00758-0

How to access this item